8 events about "Wegovy"

25 May 2026, 15:22

The European Medicines Agency has recommended the approval of the Wegovy tablet, a weight loss medication from Novo Nordisk.

Sources

International

17 April 2026, 12:22

Researchers have discovered a natural hormone that reverses obesity

Sources

+1

International

Data Talks 2026 brought together 180 leaders and experts to analyze the opportunities and risks of AI agents in companies

Sources

The European Commission has approved the 7.2 mg dose of the medication Wegovy, which can support a more pronounced weight loss.

Sources

International

24 December 2025, 07:25

Novo Nordisk's shares rose by 9.2% after the Danish company became the first to receive FDA approval for the GLP-1 pill Wegovy, intended for weight loss.

Sources

International

23 December 2025, 17:28

Novo Nordisk enters the US market with the oral weight loss pill Wegovy

Sources

International

23 December 2025, 08:52

The U.S. Food and Drug Administration (FDA) has approved the weight loss pill Wegovy, developed by Novo Nordisk.

Sources

+4

Health

17 August 2025, 08:20

Novo Nordisk has received accelerated approval for Wegovy, the first GLP-1 therapy for metabolic dysfunction-associated steatohepatitis (MASH).

Sources

International

16 October 2024, 09:14

The Novo Nordisk company is stopping the production of human insulin pen-type insulin syringes, affecting people with type 1 diabetes.

Sources

Health

Personalized news feed, AI-powered search, and notifications in a more interactive experience.

app preview

google play badge